Cidara Therapeutics Inc. (CDTX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cidara Therapeutics Inc.

    NASDAQ: CDTX · Real-Time Price · USD
    90.50
    5.74 (6.77%)
    At close: Sep 26, 2025, 3:59 PM
    90.50
    0.01%
    After-hours: Sep 26, 2025, 07:32 PM EDT

    Cidara Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -169.83M -22.93M -29.8M -42.47M
    Depreciation & Amortization
    		 233K 118K 1.23M -1.23M
    Stock-Based Compensation
    		 3.91M 3.06M 3.53M 4.01M
    Other Working Capital
    		 -33.3M 3.7M 3.3M 8.62M
    Other Non-Cash Items
    		 3.09M 1.24M 1K 15K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -13.93M -3.92M -3.43M 14.44M
    Operating Cash Flow
    		 -176.53M -22.43M -28.47M -25.23M
    Capital Expenditures
    		 -129K -505K -118K -41K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -129K -505K -118K -41K
    Debt Repayment
    		 -276K n/a -2.59M -4.44M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 7K 21K -720K 6K
    Financial Cash Flow
    		 337.06M 25.98M -951K 44.6M
    Net Cash Flow
    		 160.4M 3.05M -29.54M 19.32M
    Free Cash Flow
    		 -176.66M -22.94M -28.59M -25.27M

    Add to Watchlist